Other Events ·
Microbot Medical signs three-year exclusive distribution deal with Medtechnica for Israel
MBOTMicrobot Medical Inc.
Microbot Medical Inc. entered into a three-year exclusive commercial distribution agreement with Medtechnica Ltd., authorizing the distributor to market and sell the LIBERTY Endovascular Robotic System throughout Israel. The company received regulatory approval from the Israeli Ministry of Health’s AMAR Division in May 2026 and anticipates initial orders during the fourth quarter of 2026. This partnership supports Microbot's international expansion strategy as it prepares for potential market entry outside the U.S. Microbot Medical Inc. is a commercial stage medical device company focused on transforming endovascular procedures through advanced robotic technology.